ArticleInternal medicine journal2025
Continuous temperature monitoring for the detection of fever in haemato-oncology patients: a pilot study of two wearable devices (THERMAL).
Article in Internal medicine journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05203809 (Continuous Temperature Monitoring for tHe Early Recognition of Febrile Neutropenia in Haematological MALignancies), which is not on this map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Continuous Temperature Monitoring for tHe Early Recognition of Febrile Neutropenia in Haematological MALignancies (THERMAL)
Who cites it
2 citing papers in PubMed.
- Continuous Temperature Monitoring via Wearable Devices for Fever or Infection Management in Acute Care Hospitals: Scoping Review of Clinical Implementation and Data Analytics.JMIR mHealth and uHealth · 2026Article
- Diurnal variations of fever in children: results from an app-based observational study.BMC pediatrics · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
This pilot study explored the acceptability and feasibility of two continuous temperature monitoring devices, CORE® and TempTraq®, in 15 inpatients at risk of neutropenic fever (NF) or cytokine release syndrome (CRS) after chemotherapy, stem cell transplant or chimeric antigen receptor (CAR) T cells. Each device was worn for a median of ≥95% of the study, correlated with tympanic temperature and exhibited potential for early detection of NF or CRS (ClinicalTrials.gov NCT05203809).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.